Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Cash & Current Investments (2018 - 2025)

Historic Cash & Current Investments for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $466.2 million.

  • TransMedics' Cash & Current Investments rose 4123.25% to $466.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $466.2 million, marking a year-over-year increase of 4123.25%. This contributed to the annual value of $336.6 million for FY2024, which is 1473.16% down from last year.
  • Per TransMedics' latest filing, its Cash & Current Investments stood at $466.2 million for Q3 2025, which was up 4123.25% from $400.6 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Cash & Current Investments registered a high of $582.2 million during Q2 2023, and its lowest value of $58.1 million during Q2 2022.
  • Over the past 5 years, TransMedics' median Cash & Current Investments value was $310.1 million (recorded in 2025), while the average stood at $269.3 million.
  • Per our database at Business Quant, TransMedics' Cash & Current Investments crashed by 4825.52% in 2022 and then soared by 90237.59% in 2023.
  • TransMedics' Cash & Current Investments (Quarter) stood at $92.5 million in 2021, then skyrocketed by 117.61% to $201.2 million in 2022, then skyrocketed by 96.25% to $394.8 million in 2023, then dropped by 14.73% to $336.6 million in 2024, then soared by 38.48% to $466.2 million in 2025.
  • Its Cash & Current Investments stands at $466.2 million for Q3 2025, versus $400.6 million for Q2 2025 and $310.1 million for Q1 2025.